United States. Agency for Health Care Policy and Research & Blue Cross and Blue Shield Association. Technology Evaluation Center. (1999). Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer. [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research].
Chicago Style (17th ed.) CitationUnited States. Agency for Health Care Policy and Research and Blue Cross and Blue Shield Association. Technology Evaluation Center. Relative Effectiveness and Cost-effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostatic Cancer. [Rockville, Md.]: [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], 1999.
MLA (8th ed.) CitationUnited States. Agency for Health Care Policy and Research and Blue Cross and Blue Shield Association. Technology Evaluation Center. Relative Effectiveness and Cost-effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostatic Cancer. [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], 1999.